Vikas Lifecare [VIKASLIFE] vs Andrew Yule [ANDREWYU] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Vikas Lifecare Ltd. wins in 8 metrics, Andrew Yule & Company Ltd. wins in 10 metrics, with 0 ties. Andrew Yule & Company Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Vikas Lifecare Ltd. Andrew Yule & Company Ltd. Better
P/E Ratio (TTM) 62.00 108.71 Vikas Lifecare Ltd.
Price-to-Book Ratio 0.44 3.10 Vikas Lifecare Ltd.
Debt-to-Equity Ratio 14.39 33.31 Vikas Lifecare Ltd.
PEG Ratio 1.95 -2.87 Vikas Lifecare Ltd.
EV/EBITDA -16.74 -15.92 Andrew Yule & Company Ltd.
Profit Margin (TTM) -2.45% 3.56% Andrew Yule & Company Ltd.
Operating Margin (TTM) -4.80% -20.60% Vikas Lifecare Ltd.
Return on Equity -1.99% -0.84% Andrew Yule & Company Ltd.
Return on Assets (TTM) -1.46% -0.38% Andrew Yule & Company Ltd.
Free Cash Flow (TTM) $-2.35B $-235.61M Andrew Yule & Company Ltd.
1-Year Return -46.67% -20.31% Andrew Yule & Company Ltd.
Price-to-Sales Ratio (TTM) 0.63 3.71 Vikas Lifecare Ltd.
Enterprise Value $3.97B $12.35B Andrew Yule & Company Ltd.
EV/Revenue Ratio 0.83 4.10 Vikas Lifecare Ltd.
Gross Profit Margin (TTM) 3.19% 66.41% Andrew Yule & Company Ltd.
Revenue per Share (TTM) $2 $6 Andrew Yule & Company Ltd.
Earnings per Share (Diluted) $-0.08 $0.21 Andrew Yule & Company Ltd.
Beta (Stock Volatility) -0.41 0.46 Vikas Lifecare Ltd.

Vikas Lifecare Ltd. vs Andrew Yule & Company Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vikas Lifecare Ltd.0.00%2.07%-5.73%5.71%-20.86%-17.32%
Andrew Yule & Company Ltd.-4.00%-7.29%-13.50%20.08%2.15%4.84%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vikas Lifecare Ltd.-46.67%-47.59%-50.49%-61.13%-61.13%-61.13%
Andrew Yule & Company Ltd.-20.31%11.67%-18.56%17.64%0.53%-0.48%

Performance & Financial Health Analysis: Vikas Lifecare Ltd. vs Andrew Yule & Company Ltd.

MetricVIKASLIFEANDREWYU
Market Information
Market Cap i₹2.95B₹11.16B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,144,421232,233
90 Day Avg. Volume i5,445,663187,155
Last Close₹1.48₹23.31
52 Week Range₹1.05 - ₹2.84₹15.50 - ₹36.50
% from 52W High-47.89%-36.14%
All-Time High₹18.56 (Aug 31, 2020)₹99.70 (Jan 18, 2010)
% from All-Time High-92.03%-76.62%
Growth Metrics
Quarterly Revenue Growth0.00%0.10%
Quarterly Earnings Growth0.00%0.10%
Financial Health
Profit Margin (TTM) i-0.02%0.04%
Operating Margin (TTM) i-0.05%-0.21%
Return on Equity (TTM) i-0.02%-0.01%
Debt to Equity (MRQ) i14.3933.31
Cash & Liquidity
Book Value per Share (MRQ)₹3.67₹7.36
Cash per Share (MRQ)₹0.03₹1.04
Operating Cash Flow (TTM) i₹-2,920,476,000₹-218,291,000
Levered Free Cash Flow (TTM) i₹-106,139,000₹-28,383,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Vikas Lifecare Ltd. vs Andrew Yule & Company Ltd.

MetricVIKASLIFE (Apr 24, 2026)ANDREWYU (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i62.00108.71
Forward P/E iN/AN/A
PEG Ratio i1.95-2.87
Price to Sales (TTM) i0.633.71
Price to Book (MRQ) i0.443.10
Market Capitalization
Market Capitalization i₹2.95B₹11.16B
Enterprise Value i₹3.97B₹12.35B
Enterprise Value Metrics
Enterprise to Revenue i0.834.10
Enterprise to EBITDA i-16.74-15.92
Risk & Other Metrics
Beta i-0.410.46
Book Value per Share (MRQ) i₹3.67₹7.36

Financial Statements Comparison: Vikas Lifecare Ltd. vs Andrew Yule & Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVIKASLIFE (2025)ANDREWYU (2025)
Revenue/Sales i4.80B3.08B
Cost of Goods Sold i4.65B1.15B
COGS % of Revenue i96.9%37.3%
Gross Profit i150.32M1.93B
Gross Margin i3.1%62.7%
Research & Development iN/A1.50M
Operating Income (EBIT) i-72.65M-643.78M
Operating Margin i-1.5%-20.9%
EBITDA i31.42M-17.56M
EBITDA Margin i0.7%-0.6%
Pre-Tax Income i-128.70M-285.06M
Pre-Tax Income % of Revenue i-2.7%-9.3%
Income Tax i-19.54M-29.58M
Income Tax % of Revenue i-0.4%-1.0%
Net Income (Profit) i-109.16M-28.38M
Profit Margin i-2.3%-0.9%

Balance Sheet & Liquidity Metrics

MetricVIKASLIFE (2025)ANDREWYU (2025)
Cash & Equivalents i56.07M73.01M
Total Current Assets i2.70B2.43B
Total Current Assets % of Revenue i56.3%78.8%
Total Current Liabilities i1.53B3.63B
Total Current Liabilities % of Revenue i31.8%117.8%
Long-Term Debt i388.22M16.20M
Long-Term Debt % of Revenue i8.1%0.5%
Total Shareholders Equity i5.33B3.39B
Retained Earnings i82.78M2.07B
Retained Earnings % of Revenue i1.7%67.3%
Property, Plant & Equipment i5.88M1.88B

Cash Flow Statement Comparison

MetricVIKASLIFE (2025)ANDREWYU (2025)
Operating Cash Flow i-2.92B-218.29M
Operating Cash Flow % of Revenue i-60.8%-7.1%
Capital Expenditures i-119.53M147.05M
Free Cash Flow i-2.35B-235.61M
FCF Margin i-48.9%-7.6%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVIKASLIFEANDREWYU
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i1.86B488.95M
Float Shares i1.62B48.99M
% Held by Insiders i16.17%91.45%
% Held by Institutions i0.21%0.00%
% Held by Public i83.62%8.55%

Dividend Analysis & Yield Comparison: Vikas Lifecare Ltd. vs Andrew Yule & Company Ltd.

MetricVIKASLIFEANDREWYU
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/A0.03%
3-Year Total Dividends iN/A₹0.01
Ex-Dividend DateN/AAug 24, 2023